iCare for Cancer Patients
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer, Blood Cancer, Blood Cancer, Blood Cancer, Hematology, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/3/2019 |
| Start Date: | June 26, 2015 |
| End Date: | June 26, 2021 |
| Contact: | Barry Sawicki |
| Email: | bswcki@ufl.edu |
| Phone: | (352) 273-9148 |
The purpose of this study is to use genomic information from individual patients to create
simulation avatars that will be used to predict novel drug combinations with therapeutic
potential.
simulation avatars that will be used to predict novel drug combinations with therapeutic
potential.
As part of normal clinical care, subjects will undergo peripheral blood draws and biopsies
for disease assessment of their cancer. In cases of hematological malignancies, bone marrow
aspiration & biopsy are routinely performed.
As part of this project, the following will be done to the samples collected and with
clinical outcomes data:
- donate peripheral blood specimens whenever blood is already being drawn for clinical
purposes.
- donate bone marrow aspiration samples whenever a bone marrow aspiration procedure is
already being done for clinical purposes.
- donate saliva whenever blood draw is already being done for clinical purposes.
- allow the investigators to perform gene mutation profiling.
- allow the investigators to study gene mutation results.
- allow the investigators to perform pharmacogenetic profiling.
- allow the investigators to study pharmacogenetic profiles.
- allow the investigators to examine chromosome copy number variations.
- allow the investigators to examine genomic methylation.
- allow the investigators to quantify metabolomics/cytokines.
for disease assessment of their cancer. In cases of hematological malignancies, bone marrow
aspiration & biopsy are routinely performed.
As part of this project, the following will be done to the samples collected and with
clinical outcomes data:
- donate peripheral blood specimens whenever blood is already being drawn for clinical
purposes.
- donate bone marrow aspiration samples whenever a bone marrow aspiration procedure is
already being done for clinical purposes.
- donate saliva whenever blood draw is already being done for clinical purposes.
- allow the investigators to perform gene mutation profiling.
- allow the investigators to study gene mutation results.
- allow the investigators to perform pharmacogenetic profiling.
- allow the investigators to study pharmacogenetic profiles.
- allow the investigators to examine chromosome copy number variations.
- allow the investigators to examine genomic methylation.
- allow the investigators to quantify metabolomics/cytokines.
Inclusion Criteria:
- Individuals known or suspected of having a blood cancer or hematologic disorder
- Individuals with presence of extramedullary disease
- Capable of providing informed consent.
Exclusion Criteria:
- Does not have a blood cancer or a hematologic disorder
We found this trial at
1
site
Click here to add this to my saved trials
